Cleared Traditional

K214060 - LANDMARK REBOA Catheter (FDA 510(k) Clearance)

Sep 2022
Decision
266d
Days
Class 2
Risk

K214060 is an FDA 510(k) clearance for the LANDMARK REBOA Catheter. This device is classified as a Catheter, Intravascular Occluding, Temporary (Class II - Special Controls, product code MJN).

Submitted by Zien Medical Technologies, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on September 19, 2022, 266 days after receiving the submission on December 27, 2021.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4450.

Submission Details

510(k) Number K214060 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 2021
Decision Date September 19, 2022
Days to Decision 266 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MJN - Catheter, Intravascular Occluding, Temporary
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4450